Patients with chronic lung diseases, particularly interstitial lung disease and chronic
obstructive pulmonary disease, frequently develop pulmonary hypertension, which results in …

Pulmonary hypertension (PH) because of chronic lung disease is categorized as Group 3
PH in the most recent classification system. Prevalence of these diseases is increasing over …

Rationale: Hypersensitivity pneumonitis is a complex lung disease resulting from repeated
inhalation of a variety of antigens. Limited data exist regarding its epidemiology. Objectives …

Pulmonary hypertension (PH) developing secondarily in pulmonary fibrosis (PF) patients
(PF-PH) is a frequent co-morbidity. The high prevalence of PH in PF patients is very …

Pulmonary hypertension (PH) due to interstitial lung disease (ILD; PH-ILD) can complicate a
multitude of ILDs, including idiopathic pulmonary fibrosis, chronic hypersensitivity …

Hypersensitivity pneumonitis (HSP) is a common interstitial lung disease resulting from
inhalation of a large variety of antigens by susceptible individuals. The disease is best …

Pulmonary hypertension (PH) has been linked to worse outcomes in chronic lung diseases.
The presence of PH in the setting of underlying Interstitial Lung Disease (ILD) is strongly …

Rationale: Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease characterized by
progressive lung scarring. IPF-related pulmonary vascular remodeling and pulmonary …

Hypersensitivity pneumonitis (HP) is one of the most common interstitial lung diseases (ILD),
that presents unique challenges for a confident diagnosis and limited therapeutic options …

Pulmonary hypertension (PH) complicates the treatment of interstitial lung disease (ILD)
patients resulting in poor functional status and worse outcomes. Early recognition of PH in …